FDA Approved: FERAHEME — Supplemental Application (AMAG Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved a supplemental application for FERAHEME (ferumoxytol) to modify its labeling for iron replacement therapy in adults with iron deficiency anemia due…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Iron Deficiency Anemia

Drugs mentioned

• Feraheme (ferumoxytol)

Snippet

SUPPL AP for FERAHEME (FERUMOXYTOL)